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We first discovered autoantibodies to ACE ( angiotensin converting enzyme ) in patients with type 2 diabetes mellitus 1 . The antibodies were positive for 64.5% of the patients with diabetes and were positive in 83.3% in the early stage of clinical diabetic nephropathy. In addition, in genetically diabetogenic OLETF ( Otsuka Long-Evans Tokushima Fatty ) rats 2 , one of the characteristics of which strain is spontaneous nephropathy resembling those of human type 2 diabetes, and in control LETO rats 2 , immunization with rabbit lung ACE developed glomerulopathy similar to that seen in diabetics 3 . Also, in normal New Zealand white rabbits, immunization with the rabbit lung ACE induced glomerular changes similar to those seen in diabetic nephropathy 3 . In this study, renal tissues identical to those examined in research of diabetic nephropathy by PAS staining and electron microscope in preceding study 3 , were examined by immunostaining methods, only to prove that the diabetic glomerular changes may occur by immunization with ACE, not by non-specific responses to ACE, in non-diabetogenic rats and rabbits.
Studies on OLETF rats 3 ( referred to the former study ). To be brief, LETO(Long-Evans Tokushima Otsuka)rats, a control strain of OLETF rat, and OLETF rats were monthly immunized with rabbit lung ACE. The immunization was terminated at the 15th injection when the kidneys were extirpated for histological examinations. The kidneys were fixed by 10% formaldehyde solution and PAS stained for light microscopic examination and were fixed by 2.5% glutaraldehyde in 0.1 M PBS, pH 7.4 ( 1st fixation ) and osmium ( VIII ) oxide solution ( 2nd fixation ) for electronmicroscopic examination.
Immunoperoxidase staining of the kidney was performed in rats at Special
Reference Laboratories ( Tokyo, Japan ) as reported previously 4 . Cryosections were permeabilized with absolute ethanol, and then exposed to microwave irradiation for 10 min in 10 mM citricbuffer, pH 6.0, at 98℃, or treated with 0.05% protease ( Sigma, type XXVII), at 37℃, for 30 min for activation of the antigen. Next, sections were treated for 5 min with hydrogen peroxidase and blocked with 10 % porcine serum. After washing, sections were incubated with 3 goat anti-rat IgG ( Bethyl Lab ) or goat anti-rat IgM ( Bethyl Lab ), 1 : 100, 4℃
overnight. Anti-goat IgG ( SBA Inc. ) conjugated to horseradish peroxidase ( DAKO ) was used as secondary antibody. For staining, incubation for 7 min in 3, 3'-diaminobenzidine containing H2O2 was used. Nuclear staining was done with haematoxylin. ELISA for anti-rabbit ACE antibodies was done as reported 5 .
Studies on rabbits as a control study of the OLETF rat 3 . NZ white female rabbits were immunized with the rabbit lung ACE by monthly injections. The immunization was terminated at the 15th injection when the kidneys were extirpated for histological examinations. Then, immunoperoxidase staining of the kidney was performed as in OLETF rats.
The mean body weight of the rats was 280g for LETO rats and 350g for OLETF rats at 10 weeks old, but after the 14th immunization the same weight of 560g was shown for both groups. In immunized LETO and OLETF rats, circulating antibodies to ACE were detected from the 4th immunization on, and titers of the antibodies reached a plateau after the 6th immunization. In OLETF rats glomerular changes were observed from 10 months on. Also in LETO rats glomerular changes were demonstrated after immunization. It is reprted, by the institute which established the strain, that OLETF rats were demonstrating proliferation of the mesangial matrix and thickening of the basement membrane of glomerulus after 40 weeks of age and at 70 weeks of age a PAS-positive nodular lesion was observed in almost every glomerulus 2 . The immunization with ACE did not induce changes in early morning plasma glucose and HbA1c levels in rats and rabbits 3 .
As shown in Figs also have demonstrated progressive localization of immunoglobulins G and M, and complement C3 within the mesangium in rats made diabetic by alloxan or streptozotocin, and they stated the glomerulopathy of diabetes in rats is secondary to the abnormal metablolic environment in which the kiney resides or a consequence of the diabetic state rather than genetic disorder. In our former study 1 , autoantibodies to ACE, which were recognized most frequently in the pre-nephropathy and incipient-nephropathy stages, gradually decreased in frequency towards the final stage. This may be due to the loss of autoantibody in urine, and this loss was most prominent in the IgG of small molecule.
From the results obtained in the studies for LETO and OLETF rats, though control strain, LETO rats appear to share some of diabetogenic genes with OLETF rats 7 , it is suggested that spontaneous, "silent" deposit of immunoglobulins for ACE seen in LETO rats begins to decrease when additional deposition by immunization with ACE was added only to create the abnormal metabolic environment. On the other hand, as glomerular function becomes impaired by immunization with ACE, this leads to further glomerular pathology 5 and as nephropathy progresses the immunoglobulins gradually disappear from glomerus. However, if diabetic state exists, nephropathy can occur only by spontaneous deposition of the immunoglobulins, without additional deposit, as in OLETF rats. Also, it is very interesting that, though diabetic state does not exist, nephropathy similar to that of diabetics occurs in normal rabbit by immunization with ACE. A previous paper 8 is suggesting for OLETF rats that since disturbance of renal function exists already at 6 week-old age, before diabetes being found, specific genes independent of diabetogenic genes must be working separately for process of nephropathy. In respect of immunology, we are easily accessible to reports showing glomerular deposition of immunoglobulin or complement for unidentified antigenic substance in rat nephropathy 9, 10 .
From all the results combined 1, 3 , it is suggested that the immunoglobulin for ACE plays an important role for the occurrence of diabetic nephropathy. 
